In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $8.26 in the prior trading day, ARS Pharmaceuticals Inc (NASDAQ: SPRY) closed at $8.09, down -2.06%. In other words, the price has decreased by -$2.06 from its previous closing price. On the day, 0.53 million shares were traded. SPRY stock price reached its highest trading level at $8.18 during the session, while it also had its lowest trading level at $7.67.
Ratios:
Our goal is to gain a better understanding of SPRY by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 96.85 and its Current Ratio is at 96.85. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on March 05, 2024, Upgraded its rating to Outperform and sets its target price to $18 from $6 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 16 ’24 when Tanimoto Sarina sold 100,000 shares for $9.28 per share. The transaction valued at 928,005 led to the insider holds 1,647,447 shares of the business.
Lowenthal Richard E sold 100,000 shares of SPRY for $928,005 on Apr 16 ’24. The PRESIDENT AND CEO now owns 1,647,447 shares after completing the transaction at $9.28 per share. On Apr 09 ’24, another insider, Tanimoto Sarina, who serves as the CHIEF MEDICAL OFFICER of the company, sold 100,000 shares for $9.28 each. As a result, the insider received 927,735 and left with 1,646,494 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 780697984 and an Enterprise Value of 552611584. For the stock, the TTM Price-to-Sale (P/S) ratio is 26022.83 while its Price-to-Book (P/B) ratio in mrq is 3.38. Its current Enterprise Value per Revenue stands at 18420.387 whereas that against EBITDA is -8.193.
Stock Price History:
Over the past 52 weeks, SPRY has reached a high of $11.27, while it has fallen to a 52-week low of $2.55. The 50-Day Moving Average of the stock is -7.67%, while the 200-Day Moving Average is calculated to be 26.81%.
Shares Statistics:
The stock has traded on average 685.76K shares per day over the past 3-months and 526360 shares per day over the last 10 days, according to various share statistics. A total of 96.41M shares are outstanding, with a floating share count of 41.97M. Insiders hold about 56.51% of the company’s shares, while institutions hold 37.90% stake in the company. Shares short for SPRY as of 1713139200 were 6087282 with a Short Ratio of 8.88, compared to 1710460800 on 4254773. Therefore, it implies a Short% of Shares Outstanding of 6087282 and a Short% of Float of 10.13.
